Close Menu
Home › Rosetta Genomics Announces Reverse Stock Split

Rosetta Genomics Announces Reverse Stock Split

Mar 16, 2017

NEW YORK (GenomeWeb) – Molecular diagnostics firm Rosetta Genomics announced today that it will effect a 1-for-12 reverse stock split in order to help regain compliance with the Nasdaq Capital Market's listing requirements.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
18
Featured Webinar

Clinical Genomics of NTRK Fusion Detection in Cancer

Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19
Featured Webinar

Genome-Wide NIPT for Rare Chromosomal Conditions: Technical, Biological, and Clinical Considerations

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.

Jun
25
Featured Webinar

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

What's Popular?

In Molecular Diagnostics

  1. USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent

  2. BGI Genomics Continues to Grow Clinical Testing Business, Add Partnerships

    Premium

  3. Bio-Techne Gets New York State Approval for Prostate Cancer Test

  4. ASCO Data Pushes Boundaries for Genomic Testing in Localized Breast Cancer

    Premium

  5. Invitae Launches Free Genetic Testing Programs With Spark Therapeutics, X4 Pharmaceuticals

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.